Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca E Schweppe

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Endocrinology|June 23, 2012
Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targetsRebecca E Schweppe
Current Opinion in Endocrinology, Diabetes, and Obesity|August 11, 2018
Research ethics dilemmas in thyroid diseaseM Sara Rosenthal, Peter Angelos, Rebecca E Schweppe
Molecular Cancer|May 25, 2010
Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasionKevin T Bauerle, Rebecca E Schweppe, Bryan R Haugen
The Journal of Biological Chemistry|June 1, 2006
Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responsesRebecca E Schweppe, Tom Hiu Cheung, Natalie G Ahn
Medical Oncology (Northwood, London, England)|September 15, 2023
AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibitionMadison M Rose, Kelsey W Nassar, Vibha Sharma, et al.
Seminars in Cancer Biology|January 29, 2020
Molecular therapeutics for anaplastic thyroid cancerNikita Pozdeyev, Madison M Rose, Daniel W Bowles, et al.
Endocrine|April 2, 2003
Selective repression of rat prolactin gene by stable expression of dominant-negative Ets in GH4 pituitary cellsJohn J Tentler, Andrew P Bradford, Rebecca E Schweppe, et al.
Cancer Biology & Therapy|March 24, 2024
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapiesHannah M Hicks, Veronica L Nassar, Jane Lund, et al.
Accounts of Chemical Research|June 18, 2003
The characterization of protein post-translational modifications by mass spectrometryRebecca E Schweppe, Claire E Haydon, Timothy S Lewis, et al.
Oncotarget|June 21, 2016
Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studiesNikita Pozdeyev, Minjae Yoo, Ryan Mackie, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Endocrinology|June 23, 2012
Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targetsRebecca E Schweppe
Current Opinion in Endocrinology, Diabetes, and Obesity|August 11, 2018
Research ethics dilemmas in thyroid diseaseM Sara Rosenthal, Peter Angelos, Rebecca E Schweppe
Molecular Cancer|May 25, 2010
Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasionKevin T Bauerle, Rebecca E Schweppe, Bryan R Haugen
The Journal of Biological Chemistry|June 1, 2006
Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responsesRebecca E Schweppe, Tom Hiu Cheung, Natalie G Ahn
Medical Oncology (Northwood, London, England)|September 15, 2023
AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibitionMadison M Rose, Kelsey W Nassar, Vibha Sharma, et al.
Seminars in Cancer Biology|January 29, 2020
Molecular therapeutics for anaplastic thyroid cancerNikita Pozdeyev, Madison M Rose, Daniel W Bowles, et al.
Endocrine|April 2, 2003
Selective repression of rat prolactin gene by stable expression of dominant-negative Ets in GH4 pituitary cellsJohn J Tentler, Andrew P Bradford, Rebecca E Schweppe, et al.
Cancer Biology & Therapy|March 24, 2024
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapiesHannah M Hicks, Veronica L Nassar, Jane Lund, et al.
Accounts of Chemical Research|June 18, 2003
The characterization of protein post-translational modifications by mass spectrometryRebecca E Schweppe, Claire E Haydon, Timothy S Lewis, et al.
Oncotarget|June 21, 2016
Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studiesNikita Pozdeyev, Minjae Yoo, Ryan Mackie, et al.
Pageof 4